http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1729777-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2005-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dbe0f211594826aa5fa19af6ab4be01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba33399b665ee44e74fad23714a6d92d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2dd6af04d6ea3c688060b2abb860397
publicationDate 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1729777-B1
titleOfInvention Pharmaceutical composition comprising a salt of mirtazapine
abstract The invention provides for a pharmaceutically suitable non-sublimating and solid salt of an enantiomer of mirtazapine, in particular, a mirtazapine salt selected from the list of the salt of maleic acid, hydrobromic acid and fumaric acid, for use in the manufacture of a pharmaceutical composition comprising a salt of S- or R-mirtazapine.
priorityDate 2004-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11667949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230355006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87667650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247019276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46782381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228388294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228930882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12362975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1550213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46782643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248611742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129012699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226575828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249308524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230356801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87667942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53442681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825398

Total number of triples: 56.